CIDP Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Conditions:   Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP);   Multifocal Motor Neuropathy (MMN) Intervention:   Drug: TAK-771 Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2021 Category: Research Source Type: clinical trials